<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000001022.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:title xmlns:ns2="http://purl.org/dc/elements/1.1/">A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery</ns2:title>
    <ns3:thumbnail xmlns:ns3="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 1(B).png"/>
    <ns4:thumbnail xmlns:ns4="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 1(C).png"/>
    <ns5:thumbnail xmlns:ns5="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 1(D).png"/>
    <ns6:thumbnail xmlns:ns6="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 2(A) inset 1.png"/>
    <ns7:thumbnail xmlns:ns7="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 2(A) inset 2.png"/>
    <ns8:thumbnail xmlns:ns8="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 2(B) inset 1.png"/>
    <ns9:thumbnail xmlns:ns9="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/Creemers2021 - Fig 2(B) inset 2.png"/>
    <ns10:thumbnail xmlns:ns10="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001022.omex/curation_image.png"/>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns11:identifier xmlns:ns11="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1136/jitc-2020-002032"/>
    <ns12:label xmlns:ns12="http://www.w3.org/2000/01/rdf-schema#">Jeroen H A Creemers, W Joost Lesterhuis, Niven Mehra, Winald R Gerritsen, Carl G Figdor, I Jolanda M de Vries &amp; Johannes Textor. A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery. Journal for ImmunoTherapy of Cancer 9, 5 (2021).</ns12:label>
  </rdf:Description>
</rdf:RDF>

